Healthcare – Page 2

Avacta released its unaudited interim results for the six-month period ended 30 June 2020 on Monday. They detailed a period of significant advancement for the Group despite the restrictions placed upon it

Avacta Group plc (AVCT.L) Launch of SARS-CoV-2 BAMSTM Research Test

abm September 30, 2020

Affimer-based research assay launched alongside performance data published by Bruker

4d Pharma PLC (DDDD.L) Interim Results

abm September 30, 2020

Interim results for the six months ended 30 June 2020

Novacyt S.A. (NCYT.L) Launch of COVID-19 antibody test

abm September 29, 2020

Paris, France and Camberley, UK – 29 September 2020 – Novacyt, an international specialist in clinical diagnostics, announces that, further to the announcement on 27 July 2020, the Company has

ValiRx PLC (VAL.L) VAL201 Clinical Trial Update

abm September 28, 2020

Headline results demonstrate VAL201 has potential to be a safe and well-tolerated drug

OptiBiotix Health (OPTI.L) Exclusive distribution agreement

abm September 28, 2020

OptiBiotix Health plc (AIM: OPTI), a life sciences business developing compounds to tackle obesity, high cholesterol, diabetes and skincare,announces it has entered into an exclusive distribution agreement for SlimBiome® Medical

Open Orphan PLC (ORPH.L) New £4.3m Challenge Study Contract Win

abm September 28, 2020

Cathal Friel, Executive Chairman, Open Orphan, said: This is very exciting news as we are now signing up such challenge study contracts on a regular basis .